Benjamin F. McGraw III
InvestorVenture Partner at Sanderling Ventures · Board director at TheraVida
Find your path to Benjamin
10 people in our graph can introduce you to Benjamin.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Fred Middleton to introduce you to Benjamin
You →Fred · together at TheraVida →Benjamin
Ask Jamie Chen to introduce you to Benjamin
You →Jamie · 9 people · together at Sanderling Ventures →Benjamin
Sign up to find every way you can get introduced to Benjamin
- Your email: the people you already email who know Benjamin
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Benjamin
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Executive Chairman and CEO of TheraVida and CEO of Auration Biotech, and managing member of Long Shadows Asset Management. He previously led Valentis as Chairman/CEO, served as Corporate VP of Corporate Development at Allergan, and worked as a fund manager at Carrera Capital Management, having begun his career in pharmaceutical R&D roles at Marion Laboratories and Marion Merrell Dow. He holds BS and Doctor of Pharmacy degrees from the University of Tennessee.
Board director at TheraVida
Intro paths
In turn, Benjamin can intro founders to TheraVida's investors below.
TheraVida's investors · 1
Colleagues at Sanderling Ventures
Frequently asked questions
- Who is Benjamin F. McGraw III?
- Executive Chairman and CEO of TheraVida and CEO of Auration Biotech, and managing member of Long Shadows Asset Management. He previously led Valentis as Chairman/CEO, served as Corporate VP of Corporate Development at Allergan, and worked as a fund manager at Carrera Capital Management, having begun his career in pharmaceutical R&D roles at Marion Laboratories and Marion Merrell Dow. He holds BS and Doctor of Pharmacy degrees from the University of Tennessee.
- Where does Benjamin F. McGraw III work?
- Benjamin F. McGraw III is Venture Partner at Sanderling Ventures and Board director at TheraVida.






